Summary
Since the beginning, life on Earth has been influenced by the association between organisms and this continuous co-evolutionary process, led in life as we know it today. In this process, humans and microorganisms developed an intimate relationship known as the human microbiome. Any disturbance in our resident microbial community such as a shift away from homeostasis likely expresses itself in a pathological state. In this context, the term dysbiosis is used to describe a state of imbalance between the microbial population and the host species. E. coli, as part of our normal microbiome play an important role in homeostasis and it also has been linked to dysbiotic process. In the present chapter, we describe the role of different E. coli strains that have been linked to homeostasis and dysbiosis. Adherent Invasive E. coli (AIEC), lacking the known virulence factors of other pathogenic strains, is involved in inflammatory bowel disease (IBD). Enterohemorrhagic E. coli, together with the by-products of other members of the microbiome, colonize the human colon and E. coli Nissle is involved in maintaining homeostasis between host and its associated microbiome. The most recent studies in all Americas are also included in the present work.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ananthakrishnan AN (2015) Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 12:205–217
Barnich N (2007) CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 117:1566–1574
Barnich N, Boudeau J, Claret L, Darfeuille-Michaud A (2003) Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn’s disease. Mol Microbiol 48:781–794
Barreto I, Carmona R, Díaz F (2010) Prevalencia y características demográficas de la enfermedad inflamatoria intestinal en Cartagena, Colombia. Rev Colomb Gastroenterol 2:107–111
Baumler AJ, Tsolis RM, Heffron F (1996) The lpf fimbrial operon mediates adhesion of Salmonella typhimurium to murine Peyer’s patches. Proc Natl Acad Sci 93:279–283
Bertin Y, Chaucheyras Durand F, Robbe Masselot C et al (2013) Carbohydrate utilization by enterohaemorrhagic Escherichia coli O157:H7 in bovine intestinal content. Environ Microbiol 15:610–622
Boudeau J, Glasser A-L, Julien S et al (2003) Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn’s disease. Aliment Pharmacol Ther 18:45–56
Bringer M-A, Glasser A-L, Tung C-H et al (2006) The Crohn’s disease-associated adherent-invasive Escherichia coli strain LF82 replicates in mature phagolysosomes within J774 macrophages. Cell Microbiol 8:471–484
Carbonetto B, Fabbro MC, Sciara M et al (2016) Human microbiota of the argentine population—a pilot study. Front Microbiol 7:51
Carvalho FA, Barnich N, Sivignon A et al (2009) Crohn’s disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med 206:2179–2189
Chassaing B, Rolhion N, de Vallee A et al (2011) Crohn disease–associated adherent-invasive E. coli bacteria target mouse and human Peyer’s patches via long polar fimbriae. J Clin Invest 121:966–975
Cieza RJ, Hu J, Ross BN et al (2015) The IbeA invasin of adherent-invasive Escherichia coli mediates interaction with intestinal epithelia and macrophages. Infect Immun 83:1904–1918
Consortium THMP (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207–214
Cooney R, Baker J, Brain O et al (2010) NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 16:90–97
Croxen MA, Law RJ, Scholz R et al (2013) Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 26:822–880
Darfeuille-Michaud A (2002) Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn’s disease. Int J Med Microbiol 292:185–193
Darfeuille-Michaud A, Neut C, Barnich N et al (1998) Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn’s disease. Gastroenterology 115:1405–1413
Darfeuille-Michaud A, Boudeau J, Bulois P et al (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology 127:412–421
de Lange KM, Barrett JC (2015) Understanding inflammatory bowel disease via immunogenetics. J Autoimmun 64:91–100
de Sablet T (2009) Human microbiota-secreted factors inhibit shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 77:783–790
Desilets M, Deng X, Rao C et al (2016) Genome-based definition of an inflammatory bowel disease-associated adherent-invasive Escherichia coli pathovar. Inflamm Bowel Dis 22:1–12
Dreux N, Denizot J, Martinez-Medina M et al (2013) Point mutations in FimH adhesin of Crohn’s disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response. PLoS Pathog 9, e1003141
Eaves-Pyles T, Allen CA, Taormina J et al (2008) Escherichia coli isolated from a Crohn’s disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol 298:397–409
Economou M, Trikalinos TA, Loizou KT et al (2004) Differential effects of NOD2 variants on Crohn’s disease risk and phenotype in diverse populations: a meta-analysis. Am J Gastroenterol 99:2393–2404
Escobar JS, Klotz B, Valdes BE, Agudelo GM (2014) The gut microbiota of Colombians differs from that of Americans, Europeans and Asians. BMC Microbiol 14:1
Espinoza R, Quera R, Meyer L, Rivera D (2014) Trasplante de microbiota fecal: primer caso reportado en Chile y revisión de la literatura. Rev Chilena Infectol 31:477–482
Fabich AJ, Jones SA, Chowdhury FZ et al (2008) Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine. Infect Immun 76:1143–1152
Fischer H, Yamamoto M, Akira S et al (2006) Mechanism of pathogen‐specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur J Immunol 36:267–277
Frank DN, St Amand AL, Feldman RA et al (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci 104:13780–13785
Gibold L, Garenaux E, Dalmasso G et al (2015) The Vat-AIEC protease promotes crossing of the intestinal mucus layer by Crohn’s disease-associated Escherichia coli. Cell Microbiol 5:617–631
Hase K, Kawano K, Nochi T et al (2009) Uptake through glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune response. Nature 462:226–230
Herold S, Paton JC, Srimanote P, Paton AW (2009) Differential effects of short-chain fatty acids and iron on expression of iha in Shiga-toxigenic Escherichia coli. Microbiology 155:3554–3563
Huang SH, Wan ZS, Chen YH et al (2001) Further characterization of Escherichia coli brain microvascular endothelial cell invasion gene ibeA by deletion, complementation, and protein expression. J Infect Dis 183:1071–1078
Janka Babickova RG (2015) Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease. World J Gastroenterol 21:11321–11330
Jensen SR, Nielsen OH, Brix S (2011) Are NOD2 polymorphisms linked to a specific disease endophenotype of Crohn’s disease? Inflamm Bowel Dis 17:2392–2401
Keely S, Walker MM, Marks E, Talley NJ (2015) Immune dysregulation in the functional gastrointestinal disorders. Eur J Clin Invest 45:1350–1359
Kendall MM, Gruber CC, Parker CT, Sperandio V (2012) Ethanolamine controls expression of genes encoding components involved in interkingdom signaling and virulence in enterohemorrhagic Escherichia coli O157:H7. mBio 3:e00050–12
la Fuente DM, Franchi L, Araya D et al (2014) Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome. Int J Med Microbiol 304:384–392
Lapaquette P, Darfeuille-Michaud A (2010) Abnormalities in the handling of intracellular bacteria in Crohn’s disease. J Clin Gastroenterol 44:S26–S29
Lasaro MA, Salinger N, Zhang J et al (2009) F1C fimbriae play an important role in biofilm formation and intestinal colonization by the Escherichia coli commensal strain Nissle 1917. Appl Environ Microbiol 75:246–251
Lebeer S, Vanderleyden J, De Keersmaecker SCJ (2010) Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8(3):171–184
Lederberg J, Mccray AT (2001) ‘Ome Sweet’ omics—a genealogical treasury of words. Scientist 15:8
Lloyd SJ, Ritchie JM, Rojas-Lopez M et al (2012) A double, long polar fimbria mutant of Escherichia coli O157:H7 expresses curli and exhibits reduced in vivo colonization. Infect Immun 80:914–920
Martinez-Medina M, Garcia-Gil LJ (2014) Escherichia coli in chronic inflammatory bowel diseases: an update on adherent invasive Escherichia coli pathogenicity. World J Gastrointest Pathophysiol 5:213–227
Miquel S, Peyretaillade E, Claret L et al (2010) Complete genome sequence of Crohn’s disease-associated adherent-invasive E. coli strain LF82. PLoS One 5:e12714
Mizoguchi A, Takeuchi T, Himuro H et al (2016) Genetically engineered mouse models for studying inflammatory bowel disease. J Pathol 238:205–219
Nakanishi N, Tashiro K, Kuhara S et al (2009) Regulation of virulence by butyrate sensing in enterohaemorrhagic Escherichia coli. Microbiology 155:521–530
Nash JH, Villegas A, Kropinski AM et al (2010) Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics 11:667
Nguyen HTT, Dalmasso G, Muller S et al (2014) Crohn’s disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy. Gastroenterology 146:508–519
Nilsson LM, Thomas WE, Sokurenko EV, Vogel V (2006) Elevated shear stress protects Escherichia coli cells adhering to surfaces via catch bonds from detachment by soluble inhibitors. Appl Environ Microbiol 72:3005–3010
Nissle A (1918) Die antagonistische Behandlung chronischer Darmstörungen mit Colibakterien. Med Klin 2:29–33
O’Brien CL, Pavli P, Gordon DM, Allison GE (2014) Detection of bacterial DNA in lymph nodes of Crohn’s disease patients using high throughput sequencing. Gut 63:1596–1606
Pacheco AR, Sperandio V (2015) Enteric pathogens exploit the microbiota-generated nutritional environment of the gut. Microbiol Spectr 3(3)
Pacheco AR, Curtis MM, Ritchie JM et al (2012) Fucose sensing regulates bacterial intestinal colonization. Nature 492:113–117
Packey CD, Sartor RB (2009) Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 22:292–301
Pifer R, Sperandio V (2014) The interplay between the microbiota and enterohemorrhagic Escherichia coli. Microbiol Spectr 2(5)
Rolhion N, Barnich N, Claret L, Darfeuille-Michaud A (2005) Strong decrease in invasive ability and outer membrane vesicle release in Crohn’s disease-associated adherent-invasive Escherichia coli strain LF82 with the yfgL gene deleted. J Bacteriol 187:2286–2296
Rolhion N, Barnich N, Bringer M-A et al (2010) Abnormally expressed ER stress response chaperone Gp96 in CD favors adherent-invasive Escherichia coli invasion. Gut 59:1355–1362
Romero M, Artigiani R, Costa H et al (2008) Evaluation of the immunoexpression of COX-1, COX-2 and p53 in Crohn’s disease. Arq Gastroenterol 45:295–300
Schlee M, Wehkamp J, Altenhoefer A et al (2007) Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect Immun 75:2399–2407
Sepehri S, Khafipour E, Bernstein CN et al (2011) Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis 17:1451–1463
Short SS, Wang J, Castle SL et al (2013) Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis. Lab Invest 93:1265–1275
Small C-LN, Reid-Yu SA, McPhee JB, Coombes BK (2013) Persistent infection with Crohn’s disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat Commun 4:1957
Sokol H, Seksik P, Rigottier-Gois L et al (2006) Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 12:106–111
Sonnenborn U, Schulze J (2009) The non-pathogenic Escherichia coli strain Nissle 1917—features of a versatile probiotic. Microb Ecol Health Dis 21:122–158
Souza ÉL, Elian SD, Paula LM et al (2016) Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model. J Med Microbiol 65:201–210
Thomazini CM, Samegima D (2011) High prevalence of aggregative adherent Escherichia coli strains in the mucosa-associated microbiota of patients with inflammatory bowel diseases. Intl J Med Microbiol 6:475–479
Tobe T, Nakanishi N, Sugimoto N (2011) Activation of motility by sensing short-chain fatty acids via two steps in a flagellar gene regulatory cascade in enterohemorrhagic Escherichia coli. Infect Immun 79:1016–1024
Torres AG, Girón JA, Perna NT et al (2002) Identification and characterization of lpfABCC’DE, a fimbrial operon of enterohemorrhagic Escherichia coli O157:H7. Infect Immun 70:5416–5427
Torres AG, Kanack KJ, Tutt CB et al (2004) Characterization of the second long polar (LP) fimbriae of Escherichia coli O157:H7 and distribution of LP fimbriae in other pathogenic E. coli strains. FEMS Microbiol Lett 238:333–344
Travassos LH, Carneiro LAM, Ramjeet M et al (2010) Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 11:55–62
Vargas RD (2010) Epidemiología de la enfermedad inflamatoria intestinal: ¿por qué las diferencias entre Norteamérica y Latinoamérica? Rev Colomb Gastroenterol 25(2):103–105
Vazeille E, Chassaing B, Buisson A et al (2016) GipA factor supports colonization of Peyer’s patches by Cohn’s disease-associated Escherichia coli. Inflamm Bowel Dis 22:68–81
Victoria CR, Sassak LY, Nunes HR de C (2009) Incidence and prevalence rates of inflammatory bowel diseases, in Midwestern of São Paulo State, Brazil. Arq Gastroenterol 46:20–25
Vogt SL, Pena-Diaz J, Finlay BB (2015) Chemical communication in the gut: Effects of microbiota-generated metabolites on gastrointestinal bacterial pathogens. Anaerobe 34:106–115
Yazdanyar S, Weischer M, Nordestgaard BG (2009) Genotyping for NOD2 genetic variants and Crohn disease: a meta-analysis. Clin Chem 55:1950–1957
Zhang Y, Rowehl L, Krumsiek JM et al (2015) Identification of candidate adherent-invasive E. coli signature transcripts by genomic/transcriptomic analysis. PLoS One 10, e0130902
Zumbrun SD, Melton-Celsa AR, Smith MA et al (2013) Dietary choice affects Shiga toxin-producing Escherichia coli (STEC) O157:H7 colonization and disease. Proc Natl Acad Sci U S A 110:E2126–E2133
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Martinez de la Peña, C.F., Armstrong, G.D., Arenas-Hernández, M.M.P., Cieza, R.J. (2016). Homeostasis vs. Dysbiosis: Role of Commensal Escherichia coli in Disease. In: Torres, A. (eds) Escherichia coli in the Americas. Springer, Cham. https://doi.org/10.1007/978-3-319-45092-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-45092-6_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45091-9
Online ISBN: 978-3-319-45092-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)